Minerva Imaging is a contract research organization specializing in molecular imaging services for accelerated and efficient drug development.

We help our clients to reduce the cost and risk of drug development by incorporating preclinical imaging early in the process. In collaboration with our clients we design and conduct tailored molecular imaging protocols to i.e measure drug on target effects, eliminate dead end compounds, and increase the value of lead drug candidates. We facilitate clinical testing and design of adaptive clinical trials using molecular imaging to increase the speed of clinical testing.

Life Sciences

Research

Therapeutics

Minerva Imaging

Carsten H. Nielsen

Johan Hygum Dam

Philip Graasbøl Juul Pedersen

Lene Jessen

Katrine Vitfell Keller

Carsten Skovsborg Caselitz

Carsten Haagen Nielsen

The Leadership Team at Minerva Imaging strategically guides the organization in its mission to enhance drug development through innovative molecular imaging services. Comprising key executives, including the CEO, COO, and Chief Development Officer, the team steers company vision, operational efficiency, and growth initiatives while fostering collaborations with clients to develop tailored imaging protocols. Their collective expertise ensures that Minerva Imaging remains at the forefront of contract research, driving advancements that reduce costs and risks in drug development.

Leadership Team

Operations Team

Research and Development

Leadership Team

About

Team members

Other teams at Minerva Imaging

Operations Team

Research and Development